Grant

LIQUID FORMULATIONS OF DAPTOMYCIN

Patent Number EP-3528786-B1

Publication Year 2023

Granted Year: 2023

Application Year 2017

Priority Year 2016

Jurisdiction EP

Status Active

Inventors

GJONI TINA STRAZIC DUBRAVKA

Applicants

  1. Xellia (Denmark)

    2. [NORA names: Xellia; Private Research]

Patent Family Records (6)

liquid formulations of daptomycin  

Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA

2023, ES-2946600-T3

LIQUID FORMULATIONS OF DAPTOMYCIN

Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA

2023, EP-3528786-B1

Liquid formulations of daptomycin  

Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA

2021, US-10933019-B2

LIQUID FORMULATIONS OF DAPTOMYCIN  

Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA

2019, US-20190240155-A1

LIQUID FORMULATIONS OF DAPTOMYCIN  

Xellia (Denmark), Xellia Pharmaceuticals ApS GJONI TINA, STRAZIC DUBRAVKA

2019, EP-3528786-A1

LIQUID FORMULATIONS OF DAPTOMYCIN  

XELLIA PHARMACEUTICALS APS, Xellia (Denmark) GJONI TINA, STRAZIC DUBRAVKA

2018, WO-2018073269-A1

Data Provider: Digital Science

LINKS
-

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+